MIR7156

Across TCGA pan-cancer cohorts, MIR7156 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR7156’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MIR7156 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR7156 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

THCA, LUAD, and LUSC are the cancer types where MIR7156 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR7156 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	+0.877	<.001	9	view →
LUAD	All	All	−0.544	<.001	6	view →
LUSC	All	All	−0.397	<.001	6	view →
BRCA	All	All	+0.453	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MIR7156–THCA

Open the THCA breakdown →